NeuroPace will host an Investor Day on January 28, 2025, focusing on its RNS technology and future plans.
Quiver AI Summary
NeuroPace, Inc., a medical device company dedicated to improving the lives of epilepsy patients, has announced an Investor Day scheduled for January 28, 2025, in New York City. During the event, the company will discuss its innovative RNS technology and share insights on its recent performance, future initiatives, and strategies related to the RNS System's market, product development, and clinical applications. The program will also feature guest speakers, including clinical experts and a patient who will discuss their experiences with the RNS System's impact on managing epilepsy. NeuroPace aims to provide a unique, personalized treatment for individuals with drug-resistant epilepsy through its advanced brain-responsive platform. For registration, interested parties can visit the provided link.
Potential Positives
- NeuroPace is hosting an Investor Day, indicating proactive engagement with investors and an effort to communicate the company's strategic vision and developments.
- The event will feature presentations on recent results and future plans, showcasing the company's transparency and commitment to financial performance.
- Inclusion of guest speakers, including clinical key opinion leaders and a patient, suggests strong endorsement and positive real-world impact of the RNS technology on patient outcomes.
- The press release highlights NeuroPace's unique RNS System as a groundbreaking treatment for drug-resistant epilepsy, emphasizing its positioning as a leader in innovation within the medical device industry.
Potential Negatives
- None
FAQ
What is the date and time of NeuroPace's Investor Day?
NeuroPace's Investor Day will be held on January 28, 2025, from 9:00 a.m. to 12:00 p.m. ET.
Where is the Investor Day taking place?
The Investor Day will take place in New York City.
What will be discussed during the Investor Day?
The event will cover updates on RNS technology, company results, future plans, and clinical development strategies.
Who are the guest speakers at the event?
Guest speakers will include clinical key opinion leaders and an RNS patient sharing their personal experience.
How can I register for the NeuroPace Investor Day?
You can register for the event using the link: https://lifescievents.com/event/neuropace/.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$NPCE Insider Trading Activity
$NPCE insiders have traded $NPCE stock on the open market 29 times in the past 6 months. Of those trades, 0 have been purchases and 29 have been sales.
Here’s a breakdown of recent trading of $NPCE stock by insiders over the last 6 months:
- LTD. KCK has traded it 29 times. They made 0 purchases and 29 sales, selling 322,928 shares.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$NPCE Hedge Fund Activity
We have seen 23 institutional investors add shares of $NPCE stock to their portfolio, and 43 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- KENT LAKE CAPITAL LLC added 500,625 shares (+77.8%) to their portfolio in Q2 2024
- ARMISTICE CAPITAL, LLC added 480,000 shares (+inf%) to their portfolio in Q3 2024
- DEUTSCHE BANK AG\ removed 241,429 shares (-36.9%) from their portfolio in Q3 2024
- SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 203,776 shares (-100.0%) from their portfolio in Q2 2024
- NORTHERN TRUST CORP added 117,647 shares (+279.0%) to their portfolio in Q3 2024
- EAM INVESTORS, LLC removed 75,625 shares (-100.0%) from their portfolio in Q2 2024
- JANE STREET GROUP, LLC removed 72,013 shares (-100.0%) from their portfolio in Q2 2024
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
MOUNTAIN VIEW, Calif., Dec. 12, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that the Company will host an Investor Day from 9:00 a.m. – 12:00 p.m. ET on Tuesday, January 28, 2025 in New York City.
The Investor Day will provide an update on NeuroPace’s vision for its unique RNS technology and will highlight the Company’s plans including presentations from management discussing NeuroPace’s recent results, future plans, and market, product and clinical development strategies for the RNS System. The Company will also host guest speakers, including clinical key opinion leaders and an RNS patient who will provide their personal experience with the RNS System and its impact on their epilepsy.
Use the link below to register for the event:
https://lifescievents.com/event/neuropace/
About NeuroPace, Inc.
Based in Mountain View, Calif., NeuroPace is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is the first and only commercially available, brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients living with drug-resistant epilepsy and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders.
Investor Contact:
Jeremy Feffer
Managing Director
LifeSci Advisors
[email protected]
